1. p16 promoter methylation in Pb2+ -exposed individuals.
- Author
-
Kovatsi L, Georgiou E, Ioannou A, Haitoglou C, Tzimagiorgis G, Tsoukali H, and Kouidou S
- Subjects
- Adult, Case-Control Studies, CpG Islands drug effects, Cytosine metabolism, Humans, Lead blood, Lead toxicity, Lead Poisoning, Nervous System, Adult genetics, Male, Middle Aged, Polymerase Chain Reaction, DNA Methylation drug effects, Genes, p16 drug effects, Lead Poisoning, Nervous System, Adult physiopathology, Occupational Exposure adverse effects, Promoter Regions, Genetic
- Abstract
Background: One of the principle symptoms of lead poisoning is the development of neurological disorders. Neuronal response is closely related to DNA methylation changes. Aim. In this study, we estimated p16 methylation in nine individuals exposed to lead using methylation-specific polymerase chain reaction followed by analysis of the methylated cytosine content of the product by thermal denaturation., Results: We found that, based on lead blood concentration, lead-exposed individuals were divided into two groups. Among highly exposed individuals (blood Pb(2+) concentration = 51-100 microg/dL), we observed complete CpG methylation, whereas for low Pb(2+) concentrations (blood Pb(2+) concentration = 6-11 microg/dL), we observed partial methylation., Conclusion: Our results show that among lead-overexposed individuals, p16 methylation is frequent and extensive, and suggest that DNA methylation could be involved in the mechanism by which lead induces neurotoxicity.
- Published
- 2010
- Full Text
- View/download PDF